These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 7946423)

  • 1. [Clinical experience with sumatriptan ++ in the treatment of migraine symptoms].
    Pascual J
    Neurologia; 1994; 9(7):282-6. PubMed ID: 7946423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Subcutaneous sumatriptan in the treatment of migraine attacks. An analysis of its long term efficaciousness and tolerance].
    Leira R; Suárez C; Castillo J; Lema M; Noya M
    Rev Neurol; 1995; 23(122):752-5. PubMed ID: 7497233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
    Laloux P; Vakaet A; Monseu G; Jacquy J; Bourgeois P; van der Linden C
    Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of migraine attacks with sumatriptan].
    Pfaffenrath V
    Fortschr Med; 1993 Oct; 111(29):465-8. PubMed ID: 8258424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The efficacy of subcutaneous sumatriptan for the treatment of migraine attack].
    Stepień A
    Pol Merkur Lekarski; 1999 Jun; 6(36):326-7. PubMed ID: 10481546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan.
    Solbach MP; Waymer RS
    Obstet Gynecol; 1993 Nov; 82(5):769-72. PubMed ID: 8414324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [18 months long-term analysis of effectiveness, safety and tolerance of sumatriptan s.c. in acute therapy of migraine attacks].
    Göbel H; Stolze H; Heinze A; Dworschak M; Heuss D; Christiani K; Lindner V
    Nervenarzt; 1996 Jun; 67(6):471-83. PubMed ID: 8767202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic applications for subcutaneous triptans in the acute treatment of migraine.
    Erlichson K; Waight J
    Curr Med Res Opin; 2012 Jul; 28(7):1231-8. PubMed ID: 22401601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sumatriptan in the treatment of migraine in general practice].
    Midelfart E; Winnem M
    Tidsskr Nor Laegeforen; 1994 Nov; 114(29):3430-2. PubMed ID: 7998046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study evaluating preference for 3-mg versus 6-mg subcutaneous sumatriptan.
    Landy SH; McGinnis JE; McDonald SA
    Headache; 2005 Apr; 45(4):346-9. PubMed ID: 15836571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine. The Sumatriptan 50 mg Italian Study Group.
    Pini LA; Fabbri L; Cavazzuti L
    Int J Clin Pharmacol Res; 1999; 19(2):57-64. PubMed ID: 10669900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack.
    Linde M; Mellberg A; Dahlöf C
    Cephalalgia; 2006 Feb; 26(2):113-21. PubMed ID: 16426264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of sumatriptan injection for the treatment of morning migraine: two multicenter, prospective, randomized, double-blind, controlled studies in adults.
    Winner P; Adelman J; Aurora S; Lener ME; Ames M
    Clin Ther; 2006 Oct; 28(10):1582-91. PubMed ID: 17157114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device.
    Luthringer R; Djupesland PG; Sheldrake CD; Flint A; Boeijinga P; Danjou P; Demazières A; Hewson G
    J Pharm Pharmacol; 2009 Sep; 61(9):1219-28. PubMed ID: 19703372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP; Cady RK
    Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.